Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Amrutanjan Healthcar
Join Channel
Consolidated Standalone

Amrutanjan Healthcar

₹743.4 -0.1 | 0%

Market Cap ₹2149 Cr.

Stock P/E 49.1

P/B 7.7

Current Price ₹743.4

Book Value ₹ 96.7

Face Value 1

52W High ₹802.6

Dividend Yield 0.62%

52W Low ₹ 556.1

Edit Ratio

Amrutanjan Healthcar Research see more...

Overview Inc. Year: 1936Industry: Pharmaceuticals & Drugs

Amrutanjan Health Care Ltd is a holding organization which is engaged in manufacturing Ayurvedic Pain Balms and Beverages. It specializes in Ayurvedic balm for cold and cough, headaches. The Company's segments comprises OTC merchandise, Beverages, Chemicals and Others. The Company's body-pain portfolio includes Amrutanjan Back Pain Roll-On (ABPRO), Amrutanjan Joint Muscle Spray (JMS) and Amrutanjan Body Pain Creme. ABPRO with capsaicin-based Ayurvedic components is obtainable to address body pain. JMS is a body ache-relieving product in aerosol format, which falls under the pain relief spray segment. Amrutanjan Body Pain Creme is a body ache-relieving product in cream format and is to be had in tubes for dispensation. The Company offers Fruitnik, which is a fruit juice drink and comes in three flavours, together with Recharging Mango, Revitalising apple and Refreshing lemon. The Company additionally offers Comfy, that is a sanitary napkin logo.

Read More..

Amrutanjan Healthcar Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Amrutanjan Healthcar Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 110 111 107 71 111 98 100 78 99 117
Other Income 4 3 5 3 3 4 5 4 4 4
Total Income 115 114 112 74 114 101 105 82 103 121
Total Expenditure 87 85 90 68 95 85 87 71 92 95
Operating Profit 27 29 22 6 19 16 18 11 11 25
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 1 1 1 1 2 1 1 1 2 2
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 26 28 20 5 17 15 16 9 9 24
Provision for Tax 7 7 5 2 5 4 4 2 2 6
Profit After Tax 20 21 15 4 13 11 13 7 7 17
Adjustments 0 0 0 0 0 0 0 0 -0 -0
Profit After Adjustments 20 21 15 4 13 11 13 7 7 17
Adjusted Earnings Per Share 6.8 7 5 1.3 4.4 3.7 4.3 2.4 2.4 6

Amrutanjan Healthcar Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 135 139 163 184 212 220 253 261 333 406 380 394
Other Income 4 4 5 6 7 8 7 8 19 17 15 17
Total Income 139 143 168 190 219 228 261 270 352 423 394 411
Total Expenditure 116 116 139 153 182 192 222 231 266 328 335 345
Operating Profit 24 26 29 37 37 36 38 39 86 95 59 65
Interest 2 2 1 0 1 0 0 0 1 1 0 0
Depreciation 3 3 2 3 3 3 3 4 4 4 5 6
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 18 21 26 35 34 33 35 34 82 91 54 58
Provision for Tax 6 7 9 12 12 13 10 9 21 23 14 14
Profit After Tax 12 15 17 22 22 20 25 25 61 67 40 44
Adjustments 0 0 0 0 0 -0 0 0 0 0 0 0
Profit After Adjustments 12 15 17 22 22 20 25 25 61 67 40 44
Adjusted Earnings Per Share 4.1 5 5.9 7.7 7.5 6.9 8.4 8.6 20.9 23 13.6 15.1

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -6% 13% 12% 11%
Operating Profit CAGR -38% 15% 10% 9%
PAT CAGR -40% 17% 15% 13%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 24% 2% 21% 27%
ROE Average 14% 25% 22% 19%
ROCE Average 19% 34% 30% 28%

Amrutanjan Healthcar Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 88 97 105 120 116 129 146 159 216 265 291
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 3 3 2 3 1 1 2 2 3 4 4
Total Current Liabilities 35 24 23 25 32 32 36 39 52 77 63
Total Liabilities 127 124 130 149 149 162 183 201 271 346 358
Fixed Assets 17 15 13 22 27 28 26 26 23 28 49
Other Non-Current Assets 52 36 39 32 13 13 18 49 25 43 49
Total Current Assets 58 73 79 95 108 121 140 126 223 275 260
Total Assets 127 124 130 149 149 162 183 201 271 346 358

Amrutanjan Healthcar Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 7 9 29 31 22 10 11 15 7 3 2
Cash Flow from Operating Activities 8 18 19 21 8 19 21 18 91 52 20
Cash Flow from Investing Activities 11 16 -5 1 -0 -8 -11 -14 -88 -36 -2
Cash Flow from Financing Activities -17 -14 -12 -11 -5 -9 -7 -12 -7 -17 -15
Net Cash Inflow / Outflow 2 20 2 12 3 2 3 -7 -4 -1 3
Closing Cash & Cash Equivalent 9 29 31 42 25 11 15 7 3 2 5

Amrutanjan Healthcar Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 4.15 4.97 5.86 7.67 7.46 6.86 8.39 8.58 20.93 22.99 13.63
CEPS(Rs) 5.27 6.06 6.66 8.53 8.44 7.85 9.5 10.07 22.19 24.28 15.41
DPS(Rs) 1.5 1.6 1.75 1.93 1.93 1.95 2.15 2.1 4.2 4.6 4.6
Book NAV/Share(Rs) 30.06 33.16 35.87 41.22 39.59 44.01 49.86 54.54 73.53 90.49 99.12
Core EBITDA Margin(%) 13.54 15.38 14.37 16.33 13.41 12.77 12.21 11.79 20.2 19.11 11.73
EBIT Margin(%) 14.22 15.75 15.75 17.99 15.41 15.02 13.77 13.31 24.79 22.46 14.19
Pre Tax Margin(%) 12.52 14.58 15.39 17.89 15.16 14.88 13.69 13.18 24.61 22.32 14.13
PAT Margin (%) 8.53 9.97 9.98 11.6 9.82 9.05 9.67 9.59 18.38 16.56 10.49
Cash Profit Margin (%) 10.85 12.16 11.36 12.91 11.12 10.36 10.96 11.26 19.49 17.49 11.87
ROA(%) 9.67 11.58 13.45 16.07 14.66 12.89 14.18 13.05 25.94 21.78 11.32
ROE(%) 14.36 15.72 16.97 19.9 18.46 16.41 17.87 16.44 32.69 28.03 14.37
ROCE(%) 19.9 22.63 26.06 30.86 28.65 26.95 25.43 22.8 44 37.93 19.38
Receivable days 52.04 64.25 53.45 49.61 45.1 46.65 43.86 41.46 24.19 25.15 34.26
Inventory Days 20.91 17.07 14.77 14.28 14.75 16.79 17.96 26.73 22.58 19.54 26.36
Payable days 89.57 95.65 79.48 80.83 71.56 98.06 86.35 95.43 93.75 102.26 108.19
PER(x) 13.99 12.63 40.85 27.21 39.57 39.2 37.05 38.45 27.15 34.53 42.19
Price/Book(x) 1.93 1.89 6.67 5.06 7.45 6.11 6.23 6.05 7.73 8.77 5.8
Dividend Yield(%) 2.59 2.55 0.73 0.92 0.65 0.73 0.69 0.64 0.74 0.58 0.8
EV/Net Sales(x) 1.24 1.11 4.05 3.05 3.94 3.24 3.26 3.55 4.57 5.5 4.24
EV/Core EBITDA(x) 7.12 5.89 22.54 15.07 22.52 19.71 21.68 23.71 17.66 23.51 27.26
Net Sales Growth(%) 0.08 2.79 17.64 12.89 14.77 3.96 15.17 3.2 27.29 21.93 -6.46
EBIT Growth(%) -6.68 13.59 17.63 28.73 -1.64 -2.71 4.87 -0.27 137.11 10.5 -40.91
PAT Growth(%) -8.43 19.83 17.85 30.98 -2.76 -8.03 22.27 2.32 143.95 9.8 -40.71
EPS Growth(%) -8.43 19.83 17.85 30.98 -2.76 -8.03 22.27 2.32 143.95 9.8 -40.71
Debt/Equity(x) 0.14 0.06 0 0 0.02 0 0 0 0 0 0
Current Ratio(x) 1.63 3.01 3.42 3.76 3.35 3.75 3.87 3.22 4.28 3.55 4.12
Quick Ratio(x) 1.44 2.74 3.1 3.44 3.04 3.43 3.46 2.61 3.94 3.21 3.66
Interest Cover(x) 8.36 13.47 43.76 173.68 61.33 106.83 172.19 102.57 139.35 156.66 241.99
Total Debt/Mcap(x) 0.07 0.03 0 0 0 0 0 0 0 0 0

Amrutanjan Healthcar Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 50.02 50.02 50.02 50.02 50.02 50.04 50.04 50.59 50.59 50.59
FII 1.83 1.43 1.42 0.87 0.76 0.68 0.7 0.75 0.8 1.38
DII 6.14 6.14 6.16 6.3 6.39 7.18 7.22 7.1 7.24 7.29
Public 42.01 42.41 42.4 42.81 42.83 42.11 42.05 41.57 41.37 40.74
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 25%
  • Company is almost debt free.

Cons

  • Debtor days have increased from 102.26 to 108.19days.
  • Stock is trading at 7.7 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Amrutanjan Healthcar News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!